InvestorWire NewsRoom

InvestorNewsBreak

InvestorNewsBreaks – GridAI Technologies Corp. (NASDAQ: GRDX) Highlights Growth Strategy at Intersection of AI and Power Management
February 11, 2026

InvestorNewsBreaks – GridAI Technologies Corp. (NASDAQ: GRDX) Highlights Growth Strategy at Intersection of AI and Power Management

GridAI Technologies (NASDAQ: GRDX) is focused on advancing opportunities at the intersection of artificial intelligence and energy infrastructure following its acquisition of Grid AI, Inc. “The company recently announced that it had named Marshall Chapin as the CEO of the company’s GridAI, Inc. subsidiary,” an article discussing the company reads. “GridAI, Inc. is developing next-generation grid and power-management software for hyperscale artificial-intelligence (‘AI’) data-center campuses, providing an AI-driven energy orchestration platform that coordinates distributed energy resources across multiple scales. With the fast-growing AI-data-center market anticipated to reach $1 trillion by 2030, the need for intelligent power orchestration solutions has become critical… GridAI Inc.’s new CEO has decades of leadership experience across the grid-optimization, energy-transition, and distributed-energy sectors, and, since March 2025, Chapin has served as the Interim CEO of Amp X, an AI-driven grid-edge platform, which is also a GridAI subsidiary. His appointment shows GridAI’s commitment to deploying a top-of-the-line orchestration engine that’s able to manage the power and flexibility demands of the massive and growing AI data center market.”

To view the full article, visit https://ibn.fm/87zSn

About GridAI Technologies Corp.

GridAI Technologies is a publicly listed, diversified technology and life sciences company on the Nasdaq. The company is advancing opportunities at the intersection of artificial intelligence and energy infrastructure following its acquisition of Grid AI, Inc. In addition to its GridAI operations, the company (formerly Entero Therapeutics Inc.) continues to advance its late clinical-stage biopharmaceutical program focused on the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases.

NOTE TO INVESTORS: The latest news and updates relating to GRDX are available in the company’s newsroom at https://ibn.fm/GRDX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

Recent NewsBreaks

NewsBreaks Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).